NCT03487926View on ClinicalTrials.gov

Microglial Activation in Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions
Major Depressive EpisodeInflammatory Bowel Diseases
Interventions
RADIATION

[18F]FEPPA

up to 3 PET Scans (\[18F\]FEPPA PET scans done 3 to 6 months apart, and one \[11C\]SL2511.88 PET scan) and 1 MRI

Trial Locations (1)

M5T 1R8

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

Centre for Addiction and Mental Health

OTHER

NCT03487926 - Microglial Activation in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter